You watched
Dear buyers! Unfortunately, we are currently unable to accept the application to Canada and are revoking the license. Keep an eye on the site to see if there are any updates from Canada.
Catalog
Client
Currency:
Contacts
Our location:
Ternopil city
Contacts
E-mail
We are on social networks
Go to contacts
0 0
Catalog
Main page
Viewed
16
Wishlist
0
Compare
0
Contacts

Coolento powder sachet 4 mg 0.5 g No. 28

SKU: an-1061868
0
All about product
Description
Specification
Reviews 0
Questions0
new
Coolento powder sachet 4 mg 0.5 g No. 28
In Stock
557.84 грн.
Active ingredient:Montelukast
Adults:Children's release form
Country of manufacture:Turkey
Diabetics:With caution
Dosage:4 мг
Delivery
USPS across the USA USPS across the USA
Canada Post across Canada Canada Post across Canada
Payment
Coolento powder sachet 4 mg 0.5 g No. 28
557.84 грн.
Description

Kulento is a remedy for systemic use in obstructive airway diseases.

Indications for use

additional treatment of bronchial asthma in patients aged 6 months to 5 years with persistent mild to moderate asthma, inadequately controlled with inhaled corticosteroids, and with inadequate clinical control of asthma with short-acting β-adrenergic agonists used as needed; alternative treatment to low-dose inhaled corticosteroids for patients aged 2 to 5 years with persistent mild asthma, who have not had a recent serious asthma attack requiring oral corticosteroids, and who cannot use inhaled corticosteroids; prevention of asthma, the dominant component of which is exercise-induced bronchospasm, in patients aged 2 years and older.

Composition

1 sachet contains montelukast (as montelukast sodium) 4 mg; excipients: mannitol (E 421), low-substituted hydroxypropylcellulose, magnesium stearate.

Contraindication

Hypersensitivity to the active substance and/or to the excipients of the medicinal product.

Method of application

Dosage.

Children aged 6 months to 5 years should take 1 sachet (4 mg) once a day in the evening. No dose adjustment is required for this group of patients.

Clinical data on the efficacy of montelukast in patients with bronchial asthma aged 6 months to 2 years are limited.

In the absence of response to treatment, the use of the medicinal product should be discontinued.

The granules should be taken orally, either directly swallowed or mixed in a spoon with soft food at cold or room temperature (e.g., applesauce, ice cream, carrots, and rice).

Application features

The diagnosis of persistent bronchial asthma in children aged 6 months to 2 years should be established by a pediatrician or pulmonologist.

Patients should be advised that montelukast should never be used to treat acute asthma attacks and that they should always carry appropriate rescue medication. In the event of an acute attack, a short-acting inhaled β-agonist should be used. Patients should consult their physician as soon as possible if they require more short-acting β-agonist than usual.

You should not abruptly switch from inhaled or oral corticosteroid medications to this medication.

Pregnant women

This dosage form is used for children aged 6 months to 5 years.

Children

The drug is not recommended for use in children under 6 months of age, as the safety and effectiveness of montelukast in this age group have not been established.

Drivers

This dosage form is used for children aged 6 months to 5 years.

Overdose

In most cases of overdose, no adverse reactions were reported. The most frequently observed adverse reactions were consistent with the safety profile of montelukast and included abdominal pain, drowsiness, thirst, headache, vomiting, and psychomotor hyperactivity.

Side effects

From the nervous system: hyperkinesia.

Respiratory, thoracic and mediastinal disorders: asthma.

On the part of the digestive tract: abdominal pain, diarrhea.

Skin and subcutaneous tissue disorders: eczematous dermatitis, rash.

On the part of the body as a whole: thirst.

Storage conditions

Store at a temperature not exceeding 25°C in the original packaging and out of the reach of children.

Specifications
Characteristics
Active ingredient
Montelukast
Adults
Children's release form
Country of manufacture
Turkey
Diabetics
With caution
Dosage
4 мг
Drivers
It is impossible.
For allergies
With caution
For children
From 6 months
Form
Powders and granules
Method of application
Inside, solid
Nursing
It is impossible.
Pregnant
It is impossible.
Primary packaging
package
Producer
World Medicine
Quantity per package
28 sachets
Trade name
Coolento
Vacation conditions
By prescription
Reviews

There are no reviews for this product.

There are no reviews for this product, be the first to leave your review.

Answers & questions
Add your question and we will answer as soon as possible.

No questions about this product, be the first and ask your question.

You are watched
new
Derkast solution for infusions polymer container 100 ml
In stock
0
287.02 грн.
new
Evkabal syrup bottle 100 ml
In stock
0
357.10 грн.
new
NatHealth Cardio Omega Capsules No. 30
In stock
0
857.40 грн.
new
Blis oral solution 1 mg/ml bottle 100 ml
In stock
0
496.32 грн.
new
HerbalSeptic blackcurrant-flavored lollipops No. 24
In stock
0
332.80 грн.
new
Prednisolone ointment 0.5% tube 10 g
In stock
0
290.98 грн.
new
Sold out
Bandage 3004 arm support size 3 handkerchief
Распродано
0
579.70 грн.
new
new
Bronhomed lollipops with ivy No. 24
In stock
0
426.20 грн.